ArticlePancreas2014

Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab.

Katherine Van Loon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.